Clinical trial
Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and…
NCT00143039 · Obstetrix Medical Group, Industry · Terminated
Key facts
| NCT number | NCT00143039 |
|---|---|
| Title | Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by NIH and Severe Symmetrical IUGR |
| Official title | Amniotic Fluid Tandem Mass Spectrometry for Pregnancies Complicated by Nonimmune Hydrops and Severe Symmetrical Intrauterine Growth Restriction-A Multicenter Prospective Pilot Cohort Study |
| Acronym | TandemMS |
| Lead sponsor | Obstetrix Medical Group, Industry |
| Status | Terminated |
| Study type | Observational |
| Conditions | Hydrops Fetalis, Fetal Growth Retardation |
| Intervention type | Procedure |
| Interventions | Tandem MS test for inborn errors of metabolism |
| Enrollment | 48 |
| Start date | Mar 1, 2006 |
| Primary completion | Aug 1, 2009 |
| Completion | Aug 1, 2009 |
| First posted | Sep 2, 2005 |
| Last update posted | Dec 19, 2014 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: